|
|
|
|
|
|
|
|
|
|
Medscape
"Long-term results from 2 large studies confirm the superiority of intraperitoneal (IP) administration of chemotherapy over intravenous (IV) administration after surgery in patients with advanced ovarian cancer.
"We have known for some years that intraperitoneal administration may give superior results...but it is balanced by more toxicity," said Jubilee Brown, MD, associate professor of obstetrics and gynecology at the University of Texas M.D. Anderson Cancer Center in Houston.
The exciting thing about these data "is that at 10-year follow-up, the survival effects persist," she told Medscape Medical News.....
"The new data come from a 10-year follow-up of patients taking part in Gynecologic Oncology Group (GOG) trials 114 and 172. They were presented at the Society of Gynecologic Oncology (SOG) 44th Annual Meeting on Women's Cancer, being held in Los Angeles, California.".....
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.